JERUSALEM, Dec 11 (Reuters) â Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech (PFE.N), (22UAy. DE) COVID-19 vaccine provided significant protection against the new Omicron variant.
The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.
The study, carried out by Sheba Medical Center and the Health Ministryâs Central Virology Laboratory, compared the blood of 20 people who had received two vaccine doses 5â6 months earlier to the same number of individuals who had received a booster a month before.
Boston-based biotech Vincere Biosciences is on a mission to combat neurodegenerative disease by improving the quality of the mitochondria in our cells. The company was spun out from AI drug discovery company NeuroInitiative in 2018 after its platform identified that modulation of certain enzymes to repair mitochondrial health âmay slow or stop the progression of Parkinsonâs disease and other age-related disorders.â
In addition to seed funding, Vincere has received grants from the National Institutes of Health and Michael J Fox Foundation, and the company is now gearing up for a Series A funding round in early 2022.
Longevity. Technology: Mitochondriaâs role in longevity is a hot topic. Often referred to as the âpowerhouse of the cellâ, these miniature organs within our cells play a key role in providing the energy needed for growth, repair and rejuvenation. As we age, our mitochondria begin to decline in function, and this decline is linked to a range of age-related diseases. We caught up with Vincereâs co-founder and CEO Dr Spring Behrouz to find out how her company aims to tap into the potential of these small but mighty biological players.
The SARS-CoV-2 pandemic has generated a renaissance in vaccinology, with COVID-19 mRNA vaccines delivering a âdigital codeâ of the viral antigen with no need to purify proteins or inactivate pathogens.
One of the reasons branching identity is being accepted more seriously these days.
Beginning in the 1950s, experiments with split-brain patients revealed that consciousness could be divided between the two hemispheres of the brain. A surprising implication was that if consciousness could be divided, then it could also be combined. Evidence of this came in 2006, when conjoined twins Krista and Tatiana Hogan were born. The Hogan sisters were born with their brains connected by a thalamic bridge, which allowed a unique mental connection between them. We explore this surprising mental connection, and the possibility that we may one day connect our own minds with other conscious beings, together with what this might mean for our concept of self, identity, and the future of mind.
Please consider supporting my work on Patreon here ~ https://www.patreon.com/wakingcosmos. Thank you!
This documentary is a non-profit, educational film. All footage used with permission, or in compliance with fair use/fair dealing.
Music by Scott Buckley and Aleks Michalski. Scott Buckleyâs website: https://www.scottbuckley.com.au. Aleks Michalskiâs Bandcamp https://axen.bandcamp.com/
SEO TAGS Consciousness documentary. Split-Brain documentary. Documentary about the brain. Documentary about the mind. Krista Hogan. Tatian Hogan. Hogan Sisters. Hogan Twins. panpsychism. Waking Cosmos. The Divided Brain. The Divided Mind. Iain McGilchrist. The Master and his Emissary. The Matter with things. Michael Gazzaniga. Roger Sperry
One promising solution to plastic pollution is mycelium or mushroom packaging. It is made of 2 ingredients: mushrooms and hemp. Mycelium is the underground network of very durable, thread-like filaments called hyphae. It is mixed with agricultural waste like wood chips, oat hulls, cotton burrs or hemp hurds.
Link to my Patreon page: https://www.patreon.com/Belinda_Carr.
Chapters. 0:00 Introduction. 1:00 How its made. 2:43 Products. 4:32 Advantages. 5:30 Disadvantages. 6:19 Myths. 7:12 Conclusion.
One of the largest mushroom packaging manufacturers in the world is Ecovative Design, a New York based biotech company founded in 2006. They sent me these samples of their product. Their manufacturing process is pretty straight forward.
Their designers create a 3D CAD model of custom packaging. A CNC machine routes the design into MDF. Plastic trays are thermoformed around the MDF pieces. The tray is filled with their proprietary hemp hurd and mycelium blend. It is allowed to grow for 4 days in a controlled environment with regulated temperatures, airflow, CO2 and humidity levels. It is popped out of tray and allowed to continue growing for 2 more days to create a velvety layer of overgrowth. The packaging is then heat treated to dry out, kill spores and stop the growth process.
This material can last for 30 years in dry, temperature controlled indoor environments. It is also 100% biodegradable and a nutrient for soils and plants. When broken down into 1 cubic centimeter pieces, it will compost in just 45 days. In the ocean, it will compost in 180 days.
Pig Kidney transplant to humans: Surgeons in New York have successfully transplanted pig kidneys to two recipients in what could be a revolutionary study.
Roche and its Genentech subsidiary have committed up to $12 billion to Recursion in return for using its Recursion Operating System (OS) to advance therapies in 40 programs that include âkey areasâ of neuroscience and an undisclosed oncology indication.
Recursion OS applies machine learning and high-content screening methods in what the companies said would be a âtransformationalâ model for tech-enabled target and drug discovery.
The integrated, multi-faceted OS is designed to generate, analyze and glean insights from large-scale proprietary biological and chemical datasetsâin this case, extensive single-cell perturbation screening data from Roche and Genentechâby integrating wet-lab and dry-lab biology at scale to phenomically capture chemical and genetic alterations in neuroscience-related cell types and select cancer cell lines.
Monash University, Australia scientists have discovered an enzyme that is key to why exercise improves our health. Importantly this discovery has opened up the possibility of drugs to promote this enzymeâs activity, protecting against the consequences of aging on metabolic health, including type 2 diabetes.
The proportion of people worldwide over 60 years old will double in the next three decades and by 2031, more than six million Australians will be over 65 years old. The incidence of type 2 diabetes increases with age so this aging population will also result in an increased incidence of the disease globally.
One of the main reasons for the increased prevalence of type 2 diabetes with age is the development of insulin resistance, or an inability for the body to respond to insulin, and this is often caused by reduced physical activity as we age.
ROCHESTER, Minn. â Adding messenger RNA, or mRNA therapy improves the response to cancer immunotherapy in patients who werenât responding to the treatment, Mayo Clinic research shows. Immunotherapy uses the bodyâs immune system to prevent, control and eliminate cancer. The study is published in Cancer Immunology Research, a journal of the American Association for Cancer Research.
The phrase messenger RNA and its acronym, mRNA, have become familiar to the public during the COVID-19 pandemic. The mRNA vaccines for COVID-19 work by instructing cells in the body how to make a protein that triggers an immune response against the virus.
MRNA technology has also been of interest to cancer researchers and physicians. One of the major obstacles in cancer treatment is the low response rate in patients who receive immune checkpoint inhibitors to prevent an immune response from being so strong that it destroys healthy cells in the body.
